Theodore R. Schroeder, President, CEO at CADENCE PHARMACEUTICALS INC (CADX), sold 50,000 shares at $9.30 ($459K) on 2010-03-31, disclosed to the SEC on 2010-04-01.
Scheduled sale ($459k) by President, CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.30 | 28,003 | $260K | 56.7% |
| 2 | $9.03 | 21,997 | $199K | 43.3% |
| Total | $9.18 avg | 50,000 | $459K | 100% |
| Filing → |
| NBRV | BUY | 2019-08-28 | $90K | — | Filing → |
| CADX | BUY | 2011-05-17 | $120K | — | Filing → |
| CADX | SELL | 2010-10-04 | $418K | — | Filing → |